|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/26 | |
| A61K 45/06 | |||
| A61K 31/426 | |||
| A61K 31/4985 | |||
| A61P 3/06 | |||
| A61P 3/10 | |||
| A61P 9/10 | |||
| A61P 9/12 | |||
| A61P 3/04 | |||
| A61K 38/22 |
| (11) | Number of the document | 2849776 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13726933.8 |
| Date of filing the European patent application | 2013-05-15 | |
| (97) | Date of publication of the European application | 2015-03-25 |
| (45) | Date of publication and mention of the grant of the patent | 2021-04-21 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2013/041076 |
| Date | 2013-05-15 |
| (87) | Number | WO 2013/173417 |
| Date | 2013-11-21 |
| (30) | Number | Date | Country code |
| 201261648110 P | 2012-05-17 | US |
| (72) |
VALCARCE LOPEZ, Maria Carmen, US
FONG, Tung, US
|
| (73) |
vTv Therapeutics LLC ,
3980 Premier Drive, Suite 310, High Point, NC 27265,
US
|
| (54) | GLUCOKINASE ACTIVATOR COMPOSITIONS FOR THE TREATMENT OF DIABETES |
| GLUCOKINASE ACTIVATOR COMPOSITIONS FOR THE TREATMENT OF DIABETES |